Dr. Christopher Barker, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Skin Cancer
Studies Squamous Cell Carcinoma
6 reported clinical trials
11 drugs studied
Area of expertise
1Skin Cancer
Stage IV
Stage III
2Squamous Cell Carcinoma
Stage III
Affiliated Hospitals
Clinical Trials Christopher Barker, MD is currently running
Axitinib + Nivolumab
for Melanoma
The researchers are doing this study to find out whether the combination of axitinib and nivolumab is an effective and safe treatment for people with advanced or metastatic mucosal melanoma that has not been treated before. The researchers think that a combination of axitinib and nivolumab may help people with this disease because both drugs target and block proteins that play a role in cancer cell survival and growth. The researchers think the drugs may be more effective if given in combination rather than on their own.
Recruiting1 award Phase 2
Avelumab + Radiation Therapy
for Merkel Cell Carcinoma
This study will test the use of comprehensive ablative radiation therapy (CART), with the immunotherapy drug avelumab, in people with Merkel cell carcinoma (MCC) that has progressed after treatment and cannot be removed with surgery. The study researchers want to find out if CART works well when combined with avelumab.
Recruiting1 award Phase 211 criteria
More about Christopher Barker, MD
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Christopher Barker, MD has experience with
- Electronic Skin Surface Brachytherapy
- Cemiplimab
- Radiotherapy
- Radiation Therapy
- Reflectance ConfocaL Microscopy And Optical Coherence Tomography Guided
- Avelumab
Breakdown of trials Christopher Barker, MD has run
Skin Cancer
Squamous Cell Carcinoma
Basal cell carcinoma
Basal Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christopher Barker, MD specialize in?
Christopher Barker, MD focuses on Skin Cancer and Squamous Cell Carcinoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Christopher Barker, MD currently recruiting for clinical trials?
Yes, Christopher Barker, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Christopher Barker, MD has studied deeply?
Yes, Christopher Barker, MD has studied treatments such as Electronic Skin Surface Brachytherapy, Cemiplimab, Radiotherapy.
What is the best way to schedule an appointment with Christopher Barker, MD?
Apply for one of the trials that Christopher Barker, MD is conducting.
What is the office address of Christopher Barker, MD?
The office of Christopher Barker, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.